The effect of carbon dioxide on inhaled antibiotics in bronchiectasis patients.
- Conditions
- BronchiectasisMedDRA version: 14.1Level: LLTClassification code 10006446Term: Bronchiectasis NOSSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
- Registration Number
- EUCTR2012-001541-40-NL
- Lead Sponsor
- Vu University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Bronchiectasis
Antibiotic inhalation treatment
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 11
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 3
;
Bronchiectasis
Antibiotic inhalation treatment
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 11
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 3
oAge <21 years.
oChronic respiratory insufficiency defined according to the GOLD criteria (PaO2 < 60 mmHg or PaCO2 > 50 mmHg, WHO Global Initiative for Chronic Obstructive Lung Disease 2006)
oRenal insufficiency defined as renal creatinine clearance of < 30 ml/minute.
oNeuromuscular diseases.
oImpaired hearing
oPregnant or breastfeeding.
oBronchiectasis exacerbation during last 4 weeks.
oHistory of panic attacks
;
oAge <21 years.
oChronic respiratory insufficiency defined according to the GOLD criteria (PaO2 < 60 mmHg or PaCO2 > 50 mmHg, WHO Global Initiative for Chronic Obstructive Lung Disease 2006)
oRenal insufficiency defined as renal creatinine clearance of < 30 ml/minute.
oNeuromuscular diseases.
oImpaired hearing
oPregnant or breastfeeding.
oBronchiectasis exacerbation during last 4 weeks.
oHistory of panic attacks
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method